SM
Sciencast Management’s Edwards Lifesciences EW Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,872
| Closed | -$208K | – | 294 |
|
|
2025
Q1 | $208K | Buy |
+2,872
| New | +$208K | 0.05% | 221 |
|
|
2024
Q3 | – | Sell |
-25,483
| Closed | -$2.35M | – | 277 |
|
|
2024
Q2 | $2.35M | Buy |
+25,483
| New | +$2.35M | 0.82% | 45 |
|
|
2023
Q4 | – | Sell |
-15,009
| Closed | -$1.04M | – | 285 |
|
|
2023
Q3 | $1.04M | Buy |
+15,009
| New | +$1.04M | 0.47% | 67 |
|
|
2022
Q2 | – | Sell |
-27,022
| Closed | -$3.19M | – | 465 |
|
|
2022
Q1 | $3.19M | Buy |
+27,022
| New | +$3.19M | 0.73% | 32 |
|
|
2021
Q1 | – | Sell |
-9,932
| Closed | -$869K | – | 546 |
|
|
2020
Q4 | $869K | Buy |
+9,932
| New | +$869K | 0.18% | 177 |
|
|
2020
Q2 | – | Sell |
-8,700
| Closed | -$1.64M | – | 438 |
|
|
2020
Q1 | $1.64M | Buy |
+8,700
| New | +$1.64M | 0.46% | 12 |
|
|
2019
Q3 | – | Sell |
-8,600
| Closed | -$1.67M | – | 391 |
|
|
2019
Q2 | $1.67M | Buy |
+8,600
| New | +$1.67M | 0.94% | 7 |
|
|
2017
Q4 | – | Sell |
-11,086
| Closed | -$1.14M | – | 345 |
|
|
2017
Q3 | $1.14M | Buy |
11,086
+7,647
| +222% | +$783K | 0.63% | 44 |
|
|
2017
Q2 | $407K | Sell |
3,439
-450
| -12% | -$53.3K | 0.23% | 166 |
|
|
2017
Q1 | $366 | Buy |
+3,889
| New | +$366 | 0.2% | 176 |
|
|
2016
Q3 | – | Sell |
-4,300
| Closed | -$429K | – | 156 |
|
|
2016
Q2 | $429K | Sell |
4,300
-400
| -9% | -$39.9K | 0.19% | 173 |
|
|
2016
Q1 | $415K | Sell |
4,700
-640
| -12% | -$56.5K | 0.33% | 103 |
|
|
2015
Q4 | $422K | Buy |
+5,340
| New | +$422K | 0.44% | 83 |
|